LXRX

Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX)

About Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX)

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Details

Daily high

$0.76

Daily low

$0.71

Price at open

$0.75

52 Week High

$2.45

52 Week Low

$0.28

Market cap

272.4M

Dividend yield

0.00%

Volume

4.3M

Avg. volume

3.8M

P/E ratio

-1.46

Lexicon Pharmaceuticals, Inc. - Common Stock News